Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease.

The Journal of antimicrobial chemotherapy - 1 Oct 2015

Ferro Beatriz E, van Ingen Jakko, Wattenberg Melanie, van Soolingen Dick, Mouton Johan W

Abstract excerpt

OBJECTIVES: This study aimed to provide basic pharmacodynamic information for key antibiotics used to treat Mycobacterium avium and Mycobacterium xenopi pulmonary disease. METHODS: M. avium subspecies hominissuis IWGMT49 and M. xenopi ATCC 19250 type strains were used; the MICs of clarithromycin, amikacin and moxifloxacin were determined by broth microdilution. Time-kill assays were performed, exposing bacteria...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amikacin
Share to Anti-Bacterial Agents
Share to Clarithromycin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dose-Response Relationship, Drug

Share to Drug Resistance, Bacterial

Share to Microbial Sensitivity Tests

Share to Mutation Rate

Share to Mycobacterium avium

Source

Identifiers

PMID: 26142475
DOI: 10.1093/jac/dkv180

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease.PMID 26142475Read ↗

Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.Semantic proximity Read ↗

Time-dependent pharmacodynamics of amikacin on Mycobacterium abscessus growth and resistance emergenceSemantic proximity Read ↗

Mechanisms of Antibiotic Tolerance in Mycobacterium avium Complex: Lessons From Related MycobacteriaSemantic proximity Read ↗

Divergent Minimum Inhibitory Concentrations of Clarithromycin and Azithromycin Against Clinical Isolates of <i>Mycobacterium abscessus</i> ComplexSemantic proximity Read ↗

Divergent MIC of Clarithromycin and Azithromycin Against Clinical Isolates of <i>Mycobacterium abscessus</i> ComplexSemantic proximity Read ↗

Pulmonary Distribution and Lesion Penetration of Antimicrobials in Patients with Nontuberculous Mycobacterial DiseaseSemantic proximity Read ↗

Potential Efficacy of Streptomycin in Amikacin-resistant <i>Mycobacterium avium-intracellulare</i> Complex Pulmonary DiseaseSemantic proximity Read ↗

Drug Susceptibility Testing of Nontuberculous MycobacteriaSemantic proximity Read ↗

Mycobacterium avium ssp. hominissuis biofilm is composed of distinct phenotypes and influenced by the presence of antimicrobials.Semantic proximity Read ↗

Antibiotic Susceptibility and Genotyping of Mycobacterium avium Strains That Cause Pulmonary and Disseminated Infection.Semantic proximity Read ↗

Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae.Semantic proximity Read ↗

Antimicrobial resistance of rapidly growing mycobacteria isolated from companion animals in TaiwanSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.